Resources

Case studies, publications, and dashboard how-tos from trials we have run.

Spotlight

What happens before the sample hits the cytometer

Fresh-X compared fresh, cryopreserved, and TokuKit-fixed whole blood across the same draws. Fixation held populations that freezing lost.

Read the study

Proof from trials

All case studies

Case study

Leading cell therapy developer scales 25 marker spectral flow panel to 280+ samples in multi-cohort trial

Longitudinal spectral flow cytometry profiling of 280+ samples to support a complex Phase I/II dose escalation trial.

Read the case study

Case study

AML drug developer selects Teiko for 500+ specimen trial

The goal is to assess dose-dependent drug effects on AML blasts and immune cells using TokuKit fixation. Teiko’s 43-marker CyTOF panel processes ~500 samples. Results track 700+ subsets. The developer cut specimens from 3 to 1, saving ~$200 each, capturing responses within 30 minutes. Runtime is ongoing.

Read the case study

Case study

Public immunotherapy developer uses 40+ parameter cytometry to uncover immune cells driving response in ~200 blood samples in Phase 1 study

A $5B+ immunotherapy company aimed to assess drug impact on immune cell composition in 20 healthy volunteers across two doses and placebo in Phase 1. Teiko’s 42-marker panel analyzed 200 PBMC samples over 6.5 weeks. Results confirmed myeloid subset changes and significant T cell shifts, increasing resolution 17X to 858 subsets for indication selection.

Read the case study